Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer
- 3 March 2021
- journal article
- review article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 19 (3), 194-198
- https://doi.org/10.1016/j.clgc.2020.12.003
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Urinary markers for bladder cancerF1000Prime Reports, 2013
- Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA GuidelineJournal of Urology, 2012
- A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with HematuriaJournal of Urology, 2012
- Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective TrialJournal of Urology, 2012
- Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic ReviewEuropean Urology, 2011
- Quality of care in patients with bladder cancerCancer, 2011
- Micropapillary bladder cancerCancer, 2007
- Urine Cytology DiscrepanciesAmerican Journal of Clinical Pathology, 2007
- Flexible Cystoscopy Assisted by Hexaminolevulinate Induced Fluorescence: A New Approach for Bladder Cancer Detection and Surveillance?European Urology, 2005
- p53 Immunohistochemistry as a Prognostic Marker in Bladder CancerEuropean Urology, 2000